This article describes a new, combined, quantitative method for assessing excipient risks that has been developed by the authors as one possible risk evaluation method.
Tetiana Kolisnyk
Advertisement
Articles by Tetiana Kolisnyk
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmSci 360: Build the Device Into Dosage Form Development From Day One
2
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
3
Why Impurity Deficiencies Keep Repeating: AAPS PharmSci 360 2026
4
Why Drug Shortages Average 5+ Years: PharmTech Explained
5